Tag: FDA label revision 2024

Home / FDA label revision 2024

Categories

FDA revises pembrolizumab’s indication for gastric cancer

The Food and Drug Administration updated the approved use of pembrolizumab (Keytruda, Merck) in combination with trastuzumab, fluoropyrimidine, and platinum-containing chemotherapy for treating HER2...
fda-label-revision-2024

Scan the code